Fitoterapia2022,Vol.1618.DOI:10.1016/j.fitote.2022.105257

Meroterpenoids with a large conjugated system from Ganoderma lucidum and their inhibitory activities against renal fibrosis

Wang Y.-X. Huang L.-S.-X. Peng Y.-L. Lv Q. Cheng Y.-X. Qiu B.
Fitoterapia2022,Vol.1618.DOI:10.1016/j.fitote.2022.105257

Meroterpenoids with a large conjugated system from Ganoderma lucidum and their inhibitory activities against renal fibrosis

Wang Y.-X. 1Huang L.-S.-X. 1Peng Y.-L. 2Lv Q. 2Cheng Y.-X. 2Qiu B.3
扫码查看

作者信息

  • 1. Key Laboratory of Chemistry in Ethnic Medicinal Resources State Ethnic Affairs Commission & Ministry of Education School of Ethnic Medicine Yunnan Minzu University
  • 2. Institute for Inheritance-Based Innovation of Chinese Medicine School of Pharmaceutical Sciences Health Science Center Shenzhen University
  • 3. Yunnan University of Chinese Medicine
  • 折叠

Abstract

© 2022Baoslingzhines A–E (1–5), five new meroterpenoids were isolated from the fruiting bodies of Ganoderma lucidum. The structures including their absolute configurations were characterized by using spectroscopic and computational methods. Compound 1 is a novel trinormeroterpenoid featuring the presence of an unusual dihydronaphthalene representing an unprecedented meroterpenoid skeleton. Compounds 2–4 are mononormeroterpenoids characteristic of a large conjugated system. Among them, racemic 3 and 4 were separated by HPLC on chiral phase. Biological evaluation toward kidney fibrosis found that compounds 2 and (+)-3 could inhibit the expression of fibronectin and collagen I dose dependently in TGF-β1-induced rat kidney proximal tubular cells (NRK-52e). Additionally, (+)-3 could also down regulate ɑ-SMA in a concentration dependent manner. Further investigation showed that 2 could inhibit Smad2 phosphorylation.

Key words

Ganoderma lucidum/Large conjugated system/Meroterpenoids/Renal fibrosis

引用本文复制引用

出版年

2022
Fitoterapia

Fitoterapia

SCI
ISSN:0367-326X
被引量3
参考文献量23
段落导航相关论文